BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang X, Zhai Y, Bi N, Zhang T, Deng L, Wang W, Wang X, Chen D, Zhou Z, Wang L, Liang J. Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial. Chin J Cancer Res 2021;33:53-60. [PMID: 33707928 DOI: 10.21147/j.issn.1000-9604.2021.01.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Lyu J, Jia H, Liang L, Xiao L, Liu Y, Liu X, Li K, Chen T, Zhang R, Zhang H, Tang C, Li T. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy. Future Oncol 2021;17:2647-57. [PMID: 34008415 DOI: 10.2217/fon-2021-0304] [Reference Citation Analysis]
2 Liu P, Wang GF, Peng H, Zhang L, Li XY, Zeng QM, Li Q, Zhou JH. Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis. Front Oncol 2021;11:621917. [PMID: 34912696 DOI: 10.3389/fonc.2021.621917] [Reference Citation Analysis]